Skip to content
Screener

Telomir Pharmaceuticals, Inc. TELO Q3 2025 earnings

Reported November 10, 2025 · Before market open

EPS-$0.03Beat by $0.04
EPS estimate-$0.07

Next report

Dec 2, 2026 (in a month)
Revenue estimate$500.0K
EPS estimate-$0.03

FAQ

When did Telomir Pharmaceuticals, Inc. report Q3 2025 earnings?
Telomir Pharmaceuticals, Inc. (TELO) reported Q3 2025 earnings on November 10, 2025 before market open.
What were Telomir Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
Telomir Pharmaceuticals, Inc. reported eps of $-0.03 for Q3 2025.
Did Telomir Pharmaceuticals, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.07 by $0.04.
How did Telomir Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 85.0% from $-0.20.
Where can I find Telomir Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-021712) and the 10-Q periodic report (0001493152-25-021496) directly on SEC EDGAR. The filing index links above go to sec.gov.